Integrated Diagnostics (LON:IDHC) Trading 14.3% Higher – Here’s Why

Integrated Diagnostics Holdings plc (LON:IDHC)’s stock price was up 14.3% on Saturday . The company traded as high as GBX 0.40 ($0.01) and last traded at GBX 0.40 ($0.01). Approximately 707,083 shares traded hands during mid-day trading, an increase of 283% from the average daily volume of 184,474 shares. The stock had previously closed at GBX 0.35 ($0.00).

Integrated Diagnostics Stock Performance

The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 45.72. The company’s 50 day moving average is GBX 0.36 and its 200-day moving average is GBX 0.40. The company has a market capitalization of £11.77 billion, a P/E ratio of 14.87, a price-to-earnings-growth ratio of 7.65 and a beta of 0.59.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia).